tiprankstipranks
Rimon Consulting & Management Services Ltd. (IL:RMON)
TASE:RMON
Israel Market
Want to see IL:RMON full AI Analyst Report?

Rimon (RMON) AI Stock Analysis

2 Followers

Top Page

IL:RMON

Rimon

(TASE:RMON)

Select Model
Select Model
Select Model
Neutral 46 (OpenAI - Gpt-5.6Sol)
Rating:46Neutral
Price Target:
11,505.00
▲(5.55% Upside)
Action:Reiterated
Date:08/29/26
The score is held down primarily by deteriorating cash generation (negative operating and free cash flow) alongside increased leverage, which raises financial risk. Technicals also point to weak momentum with the stock trading below key moving averages. Valuation is an additional headwind due to the high P/E and lack of dividend yield data.
Positive Factors
Multi-year revenue scaling
Strong historical revenue expansion indicates the company has built meaningful operating scale and market reach. Although recent growth has stalled, the enlarged revenue base can support future efficiency gains if demand and execution stabilize.
Negative Factors
Negative operating and free cash flow
Sustained negative operating and free cash flow weakens earnings quality and financial resilience. It signals working-capital pressure or poor cash conversion and may require external financing or balance-sheet support to fund operations.
Read all positive and negative factors
Positive Factors
Negative Factors
Multi-year revenue scaling
Strong historical revenue expansion indicates the company has built meaningful operating scale and market reach. Although recent growth has stalled, the enlarged revenue base can support future efficiency gains if demand and execution stabilize.
Read all positive factors

Rimon (RMON) vs. iShares MSCI Israel ETF (EIS)

Rimon Business Overview & Revenue Model

Company Description
Established in Caesarea, Israel in 1997, Rimon Consulting & Management Services Ltd. is a multifaceted company specializing in critical infrastructure across the water, energy, and natural gas sectors. In the water domain, Rimon develops, owns, an...

Rimon Financial Statement Overview

Summary
Despite solid multi-year revenue scaling and still-positive profitability (TTM operating margin ~9.6%, EBITDA margin ~14.7%), results have softened: TTM revenue declined (~-2.75%) and net margins compressed (~4.2%). The biggest drag is cash quality—operating cash flow and free cash flow are negative in 2025 and TTM—paired with higher leverage (debt-to-equity ~1.36), reducing flexibility.
Income Statement
64
Positive
Balance Sheet
58
Neutral
Cash Flow
29
Negative
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue1.57B1.47B910.79M748.93M460.93M291.87M
Gross Profit279.05M254.73M144.82M120.06M93.83M35.90M
EBITDA215.31M217.17M143.12M129.83M97.56M51.40M
Net Income58.21M66.06M60.02M63.88M51.77M29.48M
Balance Sheet
Total Assets2.21B2.05B1.55B1.12B980.16M842.72M
Cash, Cash Equivalents and Short-Term Investments288.03M302.31M372.39M139.30M268.09M299.38M
Total Debt872.15M826.82M647.55M325.49M260.67M226.42M
Total Liabilities1.53B1.38B1.02B618.25M501.98M407.30M
Stockholders Equity614.11M594.91M529.19M503.18M476.89M433.18M
Cash Flow
Free Cash Flow-132.81M-199.92M20.36M25.94M-6.49M24.72M
Operating Cash Flow-32.41M-112.82M113.45M64.94M26.74M44.10M
Investing Cash Flow-97.19M-40.72M-146.54M-185.76M-60.31M-57.37M
Financing Cash Flow122.84M87.83M273.83M-7.89M-2.10M249.08M

Rimon Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
58
Neutral
₪8.76B45.360.81%14.01%-10.85%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
54
Neutral
₪3.54B21.785.00%-2.12%-9.77%
46
Neutral
₪4.62B72.9240.30%-5.49%
45
Neutral
₪15.44B45.740.48%18.29%46.66%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IL:RMON
Rimon
11,740.00
4,616.00
64.80%
IL:SKBN
Shikun & Binui
1,781.00
332.00
22.91%
IL:ELTR
Electra
11,770.00
2,325.00
24.62%
IL:DNYA
Danya Cebus
10,650.00
-1,509.51
-12.41%
IL:LUZN
Luzon Group
457.00
168.15
58.21%
IL:SPEN
Shapir Eng
4,247.00
1,644.63
63.20%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 29, 2026